NASDAQ
1.26USD
-0.02 (-1.56%)
We have scored 8 news catalysts on Firefly Neuroscience, Inc. (AIFF) over the past 12 months. The biggest single-day move next to one of them came Mar 4, 2026, when AIFF closed +126.3%: “Firefly Neuroscience Skyrockets — Brain Scan Breakthrough Fuels Rally”. Coverage across the window leans positive (average ticker sentiment +0.76). Most of the impact sits in price momentum and short squeeze potential.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
18.6M
P/E
—
EPS
—
Beta
0.57
52W range
0.62-3.15
Day range
1.17–1.32
Open
1.26
Prev close
1.28
Volume
1.7M
Avg volume
321.1K
Dividend
0.00
IPO
2002-11-28
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Firefly Neuroscience, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of Firefly Neuroscience, Inc., taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for AIFF: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
